Showing 1,527 results

Filters Content type: News, Editors' picks, About HIV Topic: Pharmaceutical industry

News and information on drug companies, the cost of therapies, patent protections and generic medicines.

New & experimental HIV treatments

Gilead Files European Marketing Application for the Quad, a Once-Daily Single-Tablet Regimen for the Treatment of HIV Infection

Editor's pick
Gilead press release
21 December 2011
Pharmaceutical industry

Gilead's New HIV Drug Pipeline: What You Need To Know For 2012

Editor's pick
Seeking Alpha
20 December 2011
Starting treatment

New Roche Screening Test for Abacavir Hypersensitivity Available in Europe

Editor's pick
AEGiS
19 December 2011
PrEP

US to rule on preventive use of HIV drug

Editor's pick
Financial Times
16 December 2011
PrEP

Gilead Seeks FDA Approval For Truvada In Reducing HIV Risk In Uninfected Adults

Editor's pick
RTT News
15 December 2011
New & experimental HIV treatments

Novel HIV-Associated Diarrhea Drug Crofelemer Goes to FDA for Approval Review

Editor's pick
AIDSMeds.com
15 December 2011
New & experimental HIV treatments

Aethlon Medical Announces HIV-AIDS Research Discovery

Editor's pick
PR Newswire (press release)
15 December 2011
Side effects

Salix submits FDA application for Crofelemer for the Treatment of HIV-Associated Diarrhea

Editor's pick
CNBC
14 December 2011
Access to healthcare

Ukraine to produce medicaments for AIDS patients in two years - Health Ministry

Editor's pick
National News Agency of Ukraine
13 December 2011
Pharmaceutical industry

The Hepatitis C Market: Biotech’s Version of the Daytona 500

Editor's pick
Xconomy
13 December 2011
The search for a cure

Two Major Pharmaceutical Companies Take the Lead for an HIV Cure

Editor's pick
HIV-reservoir.net
13 December 2011
New & experimental HIV treatments

Gilead Announces Two-Year Data From Pivotal Phase 3 Study of Elvitegravir

Editor's pick
Market Watch
9 December 2011
Access to healthcare

AHF Praises J&J for AIDS Drug Price Cut, Asks Merck to Follow Suit

Editor's pick
Yahoo News
8 December 2011
Access to healthcare

Johnson & Johnson shuns poor people with HIV

Editor's pick
New Internationalist
8 December 2011
Pharmaceutical industry

Theratechnologies to discontinue COPD clinical program and focus on lipodystrophy

Editor's pick
Theratechnologies press release
8 December 2011
Pharmaceutical industry

Gilead Bonds Expose Discontent Shares Conceal: Corporate Finance

Editor's pick
Bloomberg Business Week
7 December 2011
Pharmaceutical industry

Pharmasset Poised to Pay 20% With Gilead Deal Closing

Editor's pick
Bloomberg Businessweek
6 December 2011
New & experimental HIV treatments

Boosting Agent Cobicistat Comparable to Norvir in Phase III Study

Editor's pick
AIDSMeds
6 December 2011
Pharmaceutical industry

Ending HIV/AIDS: Hedge Funds Believe in These 5 Companies

Editor's pick
Motley Fool
5 December 2011
Access to healthcare

Tanzania sets up production plant for HIV/AIDS medication

Editor's pick
Deutsche Welle
3 December 2011
New & experimental HIV treatments

Nearly 90 Medicines and Vaccines In Development for HIV/AIDS

Editor's pick
Pharmiweb
1 December 2011
Access to healthcare

Mylan Receives Tentative FDA Approval Through PEPFAR for First Heat-Stable, Fixed-Dose Combination of Atazanavir Sulfate and Ritonavir Tablets for HIV/AIDS

Editor's pick
Press release
1 December 2011
Sexually transmitted infections prevention

UK switches to Merck's Gardasil for HPV vaccination

Editor's pick
Reuters
26 November 2011
Pharmaceutical industry

HIV Drug Giant Gilead Acquires Pharmasset, a Hep C Drug Development Leader

Editor's pick
AIDSMeds.com
21 November 2011